HIV-positive TB patients on ART (antiretroviral therapy) in Latvia
Latvia: HIV-positive TB patients on ART (antiretroviral therapy) was 70.0% in 2017. ▲ Rising
HIV-positive TB patients on ART (antiretroviral therapy) in Latvia, 2005–2017
Source: World Health Organization, Global Health Observatory.
Analysis
Latvia recorded 70.0% for hiv-positive tb patients on art (antiretroviral therapy) in 2017.
That represents a change of up 12.9% on the previous year and up 29.6% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Latvia peaked at 77.0% in 2006 and was at its lowest, 29.0%, in 2008.
Latvia ranks 125th of 144 countries on this measure, in the bottom quarter.
The long-run direction has been consistently rising across the 13 years of available data.
HIV-positive TB patients on ART (antiretroviral therapy) in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 55.0% | — |
| 2006 | 77.0% | +40.0% |
| 2007 | 54.0% | -29.9% |
| 2008 | 29.0% | -46.3% |
| 2009 | 60.0% | +106.9% |
| 2010 | 76.0% | +26.7% |
| 2011 | 66.0% | -13.2% |
| 2012 | 57.0% | -13.6% |
| 2013 | 49.0% | -14.0% |
| 2014 | 58.0% | +18.4% |
| 2015 | 65.0% | +12.1% |
| 2016 | 62.0% | -4.6% |
| 2017 | 70.0% | +12.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 55.0% | 29.0% | 77.0% | 5 |
| 2010s | 62.9% | 49.0% | 76.0% | 8 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Latvia?
- Hiv-positive tb patients on art (antiretroviral therapy) in Latvia was 70.0% in 2017, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Latvia?
- The highest recorded value was 77.0% in 2006.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Latvia?
- The lowest recorded value was 29.0% in 2008.
- How does Latvia rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Latvia ranks 125th out of 144 countries with data for 2017.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Latvia?
- Over the last ten years it is up 29.6%. The long-run trend across the full record is rising.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 13 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).